Recent Updates
Recently added Catalysts
ESPR Positive Sentiment Score: 70/100

Esperion to Participate in Upcoming BTIG Biotech Conference

Wednesday, July 24, 2024 1 min read
Key Takeaway: Esperion Therapeutics has announced its participation in the BTIG Biotech Conference scheduled for August 5, 2024, at 4 p.m. ET. This opportunity allows Esperion to showcase its latest developments and engage with potential investors. Participation in well-known industry events typically indicates a commitment to transparency and investor relations.

Market Sentiment Analysis

POSITIVE FACTORS

  • Esperion is actively participating in a prominent biotech conference.
  • The engagement signifies possible growth and interest in their developments.
  • Involvement in such events enhances visibility among investors and stakeholders.

Full Press Release Details

ANN ARBOR, Mich., July 24, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that the company will be participating in the BTIG Biotech Conference on Monday, August 5, 2024, at 4 p.m. ET.
Esperion Therapeutics
Esperion Contact Information:
investorrelations@esperion.com
corporateteam@esperion.com

Frequently Asked Questions

When is Esperion's participation in the BTIG Biotech Conference?

Esperion will participate on August 5, 2024, at 4 p.m. ET.

Where is the BTIG Biotech Conference taking place?

The article does not specify the location of the BTIG Biotech Conference.

What is Esperion's stock symbol?

Esperion's stock symbol is NASDAQ: ESPR.

How to contact Esperion for investor relations?

You can contact Esperion at investorrelations@esperion.com.

What is the purpose of the announcement?

The announcement informs about Esperion's participation in the conference.

Tags: ESPR Viatris Investor Conferences Healthcare Esperion biotech conference BTIG investors therapeutics
Last updated: Jul 24, 2024